Safety Assessment of Pharmaceuticals

Comprehensive Toxicology, Second Edition

Volumn 3, Issue , 2010, Pages 17-28

  Hentz, K L ^a  

^a EXPONENT INC   (United States)

Author keywords

Carcinogenicity studies; Drug safety testing; EMA; FDA; Genotoxicity; Immunotoxicity; Juvenile toxicity studies; Local tolerance; MHLW; Mutagenicity; Nonclinical tests; Pharmacodynamics; Pharmacokinetics; Regulatory requirements; Repeat dose toxicity studies; Reproductive and developmental toxicity studies; Safety pharmacology; Single dose studies; Toxicokinetics

Indexed keywords

EID: 79953024930     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-046884-6.00303-1     Document Type: Chapter

References (22)

1. Davies T.S., Lynch B.S., Monro A.M., Munro I.C., Nestmann E.R. Food Chem. Toxicol. 2000, 38:219-235.
2. Scientific Guidelines for Human Medicinal Products EMA (European Medicines Agency). http://www.emea.europa.eu/htms/human/humanguidelines/nonclinical.htm.
3. FDA (US Food and Drug Administration). Federal Food, Drug, and Cosmetic Act, Pub. L. No. 75-717, 52 Stat. 1040, 1938.
4. FDA (US Food and Drug Administration). Federal Food, Drug, and Cosmetic Act as amended Pub. L. No. 87-781, Stat. 780, 1962.
5. Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals M3 1997, FDA (US Food and Drug Administration).
6. FDA (US Food and Drug Administration). Guidance for Industry and Review Staff: Recommended Approaches to Integration of Genetic Toxicology Study Results. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2006a.
7. FDA (US Food and Drug Administration). Guidance for Industry: Non-Clinical Safety Evaluation of Pediatric Drug Products. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2006b.
8. FDA (US Food and Drug Administration). Guidance Documents #Pharmacology/Toxicology (accessed 2008). http://www.fda.gov/cder/guidance/index.htm.
9. Haseman J., Melnick R., Tomatis L., Huff J. Food Chem. Toxicol. 2001, 39:739-744.
10. Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S5(R2) 1993, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
11. Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals (S2A) 1995, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
12. Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals (S2B) 1997, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
13. Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing) 1998, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
14. Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals M3(R1) 2000, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
15. Safety Pharmacology Studies for Human Pharmaceuticals (S7A) 2000, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
16. Immunotoxicity Studies for Human Pharmaceuticals S8 2006, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
17. Dose Selection for Carcinogenicity Studies of Pharmaceuticals & Limit Dose S1C(R2) 2008, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
18. Guideline on the Need for Non-Clinical Testing in Juvenile Animals of Pharamceuticals for Paediatric Indications 2008, ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).
19. PMA (Pharmaceutical Manufacturers Association). Pharmaceutical Administration and Regulations in Japan. Information in English on Japan Regulatory Affairs. English Regulatory Information Task Force, Japan, 2007.
20. Pritchard J.B., French J.E., Davis B.J., Haseman J.K. Environ. Health Perspect. 2003, 111:444-454.
21. Sontag J.M., Page N.P., Saffiotti U. Guidelines for Carcinogen Bioassay in Small Rodents 1976, 76-801. Nationl Cancer Institute, Bethesda, MD, NCI Carcinogenesis Tech. Report No. 1 DHEW Publ. No. (NIH).
22. Tominaga T., Wada K., Okubo T., Kishi K. Proceedings of ICH Tokyo Symposium: Hot Topics and Influence on Asia Tokyo 2007 2008.